Title: Microbial Resistance to Antibiotics
1Microbial Resistance to Antibiotics
Henry F. Chambers, M.D. Professor of Medicine
2Most Important Infectious Agents on the Planet
- Mycobacterium tuberculosis
- Plasmodium falciparum
- Human immunodeficiency virus
3Most Common Bacterial Pathogens on the Planet
- Mycobacterium tuberculosis
- Enterics (Salmonella enterica, Shigella sp., E.
coli) - Staphylococcus aureus
- Streptococcus sp. (S. pneumoniae, S. pyogenes)
- Neisseria sp. (N. gonorrhoeae, N. meningitidis)
- Hemophilus sp.
4Resistance is relative, depending on .
- The host and the site of infection
- The intrinsic activity of the drug and its
achievable concentration in the host - The level of susceptibility exhibited by the
microorganism at the site of infection
5Selective Pressure
Low fitness cost or compensated
Resistance
High fitness cost
Ton-Days of Antibiotics
6Compensatory Mutations
- Wild-type is best adapted, most fit
- Mutation (or acquisition of resistance genes)
comes at a cost - Cost can be compensated by
- loss of resistance (by reversion or
recombination) - by compensatory mutations
- Compensatory mutations are
- environmentally determined
- a consequence of a low recombination rate
7Example of Compensatory Mutations
- Salmonella typhimurium LT2
- SmR resistant to streptomycin (ribosomal
inhibitor) - Cost slow growth because of reduced rate of
protein synthesis - SmR passaged in broth (LB) and mice
- Mutants recovering fitness (fast growth) analyzed
for acquisition of compensatory mutations
Bjorkman, Science 287479 (2000)
8Compensatory Mutations
Bjorkman, Science 287479 (2000)
Salmonella typhimurium LT2
9Relative Fitness of SmR Mutants
Bjorkman, Science 287479 (2000)
10Resistant Strain Passaged w/o Antibiotic Pressure
Types of Mutations
Bjorkman, Science 287479 (2000)
11Effect of Bottleneck on Emergence of Compensatory
Mutations
Levin, Genetics 154985, 2000
12Compensatory Mutations
- Favored when the rate of their generation exceeds
reversion - Bottlenecks play an important role
- Function to maintain resistance (implications for
antibiotic control) - Less likely to occur if gene exchange or
recombination is common
13General Types of Resistance
- Extrinsic resistance
- Gram-neg. cocci
- Staphylococci
- Streptococci
- E. coli
- Intrinsic resistance
- M. tuberculosis
- Pseudomonas
- Enterococci
14Biochemistry of Resistance
- Antibiotic is not in an active (e.g., hydrolyzed,
modified) - Antibiotic does not reach its target (fails to
penetrate a membrane, efflux pump) - Target is changed, modified
15Genetics of Resistance
- Vertical, mutation and selection
- Fluoroquinolone resistance in all bacterial
species - All drug resistance in Mtb
- Comparatively less advantageous
- Horizontal, transfer of mobile element and
selection - Transducing phage (e.g., transfer of S. aureus
bla plasmid) - Transformation, homologous recombination (e.g.,
penicillin-resistance in pneumococci) - Conjugation (e.g., vanA resistance of
enterococci) - Comparatively more advantageous
16Mycobacterium tuberculosis A Paradigm of
Mutation-selection Mediated Resistance
17Drug Resistance in Mycobacterium tuberculosis
- MTB infects 1/3 of the worlds population
- About 10-25 of strains are resistant to at least
one drug depending on region of the world - Up to 10-20 resistant to isoniazid (INH) and
rifampin (RIF), i.e., MDR - Important cause of treatment failure
18Emergence of Resistance with Single Drug Therapy
of Active TB
Start INH alone
19Resistant Subpopulations in MTB
20Pathogenesis of Secondary Drug Resistance
Meanwhile, in the lab...
21Molecular Basis of MDR TB
- INH
- High level resistance katG (catalase) mutations
and deletions - Low level resistance inhA (mycolic acid
synthetic enzyme) overexpression - Rifampin, rifabutin, rifapentine rpoB RNA
polymerase target mutation
22Molecular Basis of MDR TB
- PZA pncA (pyrazinamidase/nicotinamidase), which
activates PZA - Fluoroquinolones gyrA (gyrase) target
alteration - Streptomycin rpsL (ribosomal protein S12) or
rrs (16S rRNA), altered binding to the ribosome - Ethambutol point mutations in embCAB gene
cluster (role in arabinoglycan synthesis)
23What about Fitness?
- High-level INH resistance is mediated by
catalase-gene deletion or mutation at the cost of
susceptibility to oxidative stress - Rifampin resistance is mediated by rpoB mutation,
which is relatively cost neutral - MDR strains generate fewer secondary cases
- But what about the W strain (Beijing)?
24Resistance Mediated by Horizontal Transfer
25Toxins and Mobile Elements
26Mobile Elements Involved in Resistance
27Resistance Integrons
28Integrons
- An integrase, gene cassette(s), and a cassette
integration site (att), a strong promoter - Not themselves mobile, but excise and integrate
cassettes that are - Found on transposons, plasmids, chromosome
- Two major groups resistance integrons and
super-integrons (presumed ancestor, 100 kb)
29Integron Structural Features
30Gene Cassettes
- Open reading frame, usually promoterless
(provided by integron) - A repeat sequence, attC, that is recognized by
integrase - Cassettes for b-lactamases, aminoglycoside
resistance, chloramphenicol resistance,
trimethoprim resistance, ciprofloxacin, etc
31(No Transcript)
32(No Transcript)
33(No Transcript)
34Integrons - Epidemiology
- Mainly found in gram-negatives, especially
enterobacteriacae (but also M. fortuitum and E.
faecalis) - Resistance integrons are interspecies
transferrable - Link between integrons in agriculatural isolates
and human isolates
35Methicillin Resistance in Staphylococcus aureus
36Beta-lactam Antibiotic Resistance of
Staphylococcus aureus
- Inactivation penicillinase (blaZ)
- Four types, relatively narrow spectrum
- Usually plasmid encoded, inducible
- Methicillin resistance target alteration
- Low affinity transpeptidase, PBP 2a (mecA)
- Inducible, chromosomal, found only in MRSA,
foreign - Can substitute for other synthetic PBPs
37(No Transcript)
38Characteristics of Community MRSA
- Associated with outbreaks, often in new
populations (e.g., children, football players,
MSM) - Specific clones, different from those typically
found in hospitals - Susceptible to many antibiotics
- SCCmec type IV
- Toxin production (Panton-Valentine leukocidin,
PVL)
39(No Transcript)
40(No Transcript)
41Common MRSA Clones
Enright, PNAS 997687, 2002
42Clonal Complexes of MRSA strains
Enright Fey Okuma
MN, MS, ND, TN Europe, Oceania, Australia
43Molecular Epidemiology of CA-MRSAEmergence of
Common Clone USA300 (ST8)
100
80
60
Football Team X MRSA, Abscess
Football Team Y MRSA, Abscess
California College Football
Pennsylvania HS Football
Colorado Fencers
California MSM
Mississippi Prison
Texas Jail
Georgia Prison
Tennessee Children
Texas Children
Missouri Children
Football Team X MSSA, Nasal
USA300 Community
USA100 Hospital strain
USA200 Hospital strain
44MRSA from Bay Area Patients, 2004-5
1 2 3 4 5 6 7 8
origin clone 1 ST
FRANCIS 1 ST8S1 2 ST FRANCIS 2
ST8S1 3 SFGH blood ST8S7 4 SFGH eye
ST8S7 5 SFGH eye ST8S1 6 UCSF eye
(HA) ST5D 7 UCSF eye ST8S1 8 MARIN CAP
ST8S1
Merl 261/2005
45PVL as a Putative Virulence Factor
- Hygiene and predisposing host conditions appear
to influence CA-MRSA colonization - PVL implicated in skin and soft-tissue infections
- May enhance spread by creating an easily
contacted reservoir shedding large numbers of
bacteria - Synergism with SCCmec ineffective antimicrobial
therapy may prolong time of shedding
46Vancomycin Resistance
47Vancomycin
- A glycopeptide, 1450 daltons
- Inhibitor of cell wall synthesis
- Target D-alanyl-D-alanine
- Interferes with transglycosylation and
transpeptidation (crosslinking) reactions - Bactericidal
48Vancomycin Use United States
VISA
VRE
49Outside cell
TG
TG transglycosylase
Inside cell
50(No Transcript)
51Players in vanA resistance
- Enterococcus faecium and E. faecalis donors
- A broad-host range conjugative plasmid
- Suitable recipient cell (pheromone producer)
- A transposon, Tn1546, resident on the plasmid
- The D-ala-D-ala target
52Map of Transposon Tn1546
53racemase
Inside cell
L-ala
D-ala D-ala
D-ala D-ala L-lys D-glu L-ala NAM
D-ala D-ala L-lys D-glu L-ala NAM
L-lys D-glu L-ala NAM
ligase
D-ala D-ala
NAG-
NAG-
Pi
Pi
NAG
Outside cell
54(No Transcript)
55Outside cell
VanY
D-ala
TG
TG transglycosylase
Inside cell
56(No Transcript)
57 O
O C
R__D-ala
C O
58Enterococcus faecalis Conjugative Plasmid
Clewell, Plasmid 48193 (2002)
59Some General Features of Conjugative Plasmids
- Tend to be relatively large gt 50kb
- A DNA transport system that combines elements of
- A DNA rolling circle replication system
- Type IV secretion system
- Plasmid encoded features
- Origin of transfer (oriT)
- DNA replicating enzymes (e.g., helicase,
relaxase, replicase) - Coupling proteins, transport proteins,
aggregating proteins - Regulators of the pheromone response
anti-pheromone
60Model of DNA Transport by a Conjugative Plasmid
Llosa, Mol Microbiol 451, 2002
61Vancomycin Resistant Staphylococcus aureus
- Intermediate presumably due to false target
overproduction MIC 8 mg/ml - vanA type three strains reported (MICs 16-1024
mg/ml) - Presumed donor E. faecalis with a vanA encoding
conjugative plasmid - Tn1546 present on a staphylococcal conjugative
plasmid, which is transferable - A residual, nontransferable presumed enterococcal
conjugative plasmid relic
62Closing Comments
- Given enough time and pressure, resistance will
eventually occur - When possible acquisition of resistance (and
probably other traits as well) occurs by
horizontal gene transfer - Compensatory mutations are a way to mitigate the
cost of resistance and maintain the trait in a
fit pool (and there may be no way back) - Hopefully, a better understanding of microbial
pathogenesis can lead to reduce antibiotic
pressure - Have a happy day!
63Additional References
- Chang S, et al. Infection with
vancomycin-resistant Staphylococcus aureus
containing the vanA resistance gene. NEJM
3481342, 2003. - De la Cruz F, and Davies J. Horizontal gene
transfer and the origin of species lessons from
bacteria. Trends Microbiol 8128, 2000. - Fluit AC and Schmitz F-J. Resistance integrons
and superintegrons. Clin Microbiol Infect
10272, 2004 - Kazakova SV, et al. A clone of methicillin-resista
nt Staphylococcus aureus among professional
football players. NEJM 352468, 2005. - Levin B and Bergstrom C. Bacteria are different
Observations, interpretations, speculations, and
opinions about the mechanisms of adaptive
evolution in prokaryotes. PNAS 976981, 2000. - Paulsen I, et al. Role of mobile DNA in the
evolution of vancomycin-resistant Enterococcus
faecalis. Science 2992071, 2003 - Tenaillon O, et al. Mutators and sex in bacteria
conflict between adaptive strategies. PNAS
9710465, 2000.